27 recruiting, 22 unknown, 11 active not recruiting, 8 completed. 28 Not applicable, 2 Phase 2, 1 Early Phase 1.
Follow Liquid Biopsy: new trials by email Literature Review of Liquid Biopsy trials Research Report on Liquid Biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System Novel CRISPR/Cas12a Electrochemical Bioassay, Reference Standard Molecular Diagnostics (NGS and ddPCR), Serial Peripheral Blood Sampling for Liquid Biopsy - Unresectable Metastatic Melanoma | Not applicable | Recruiting | Masaryk Memorial Cancer Institute | 17 | 2026-10-20 | 2026-10-16 |
| Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer Bile Sampling for ctDNA Analysis - Biliary Tract Cancer (BTC) | Not yet recruiting | CHA University | 100 | 2026-10-01 | 2026-10-13 | |
| The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUTURE Trial FAPI PET/CT and liquid biopsy in patients eligible for radical cystectomy, FAPI PET/CT and liquid biopsy in patients eligible for conservative treatment - Bladder Cancer | Phase 2 | Not yet recruiting | Chiti Arturo | 262 | 2026-09-01 | 2025-12-02 |
| Advancing Risk Stratification in Endometrial Cancer Liquid Biopsy - Endometrial Cancer | Active not recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 400 | 2026-07-23 | 2026-08-04 | |
| Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer Liquid biopsy - Bladder Cancer | Active not recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 300 | 2025-10-01 | 2026-07-30 | |
| ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer Blood Sampling for ctDNA Analysis - Biliary Tract Cancer | Recruiting | CHA University | 100 | 2025-09-01 | 2026-03-18 | |
| Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC Circulating Tumor DNA (ctDNA) Testing (ctDNA-based Next-Generation Sequencing (NGS)) - Biliary Tract Cancer | Recruiting | CHA University | 200 | 2025-09-01 | 2026-03-18 | |
| Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain Liquid Biopsy, Archival Tumor DNA - Metastatic Breast Cancer | Recruiting | SOLTI Breast Cancer Research Group | 300 | 2025-05-20 | 2025-05-28 | |
| Smart Measurement of Circulating Tumor DNA Blood Product - Colorectal Neoplasms, Colorectal Neoplasms Malignant | Not applicable | Recruiting | Erasmus Medical Center | 50 | 2025-05-16 | 2025-08-11 |
| Early Diagnosis and Recurrence Monitoring of Colorectal Cancer Liquid biopsy - Colorectal Cancer | Not yet recruiting | Huashan Hospital | 1200 | 2025-05-01 | 2025-05-28 | |
| Liquid Biopsies for the Detection of Somatic Mutations in bAVMs liquid biopsies and surgery specimen analysis - Brain Arterial Disease | Recruiting | Assistance Publique - Hôpitaux de Paris | 50 | 2025-04-01 | 2026-08-31 | |
| Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer liquid biopsy - Colorectal Cancer, Colorectal Adenoma | Recruiting | Helse Nord-Trøndelag HF | 3000 | 2025-03-10 | 2025-04-30 | |
| Precision Medicine for L/GCMN and Melanoma 2 Breath analyzer, Skin patch, Liquid biopsy - Melanoma (Skin Cancer), Nevi and Melanomas | Recruiting | Fundacion Clinic per a la Recerca Biomédica | 100 | 2025-01-01 | 2025-02-27 | |
| Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals Liquid Biopsy (SPOT-MAS Assay), Exosome-Based Liquid Biopsy Assay, Low-Dose CT Thorax (LDCT) - Lung Cancer, Lung Neoplasms | Not applicable | Recruiting | National University Hospital, Singapore | 140 | 2024-11-01 | 2026-01-22 |
| Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab lenvatinib plus pembrolizumab - Biliary Tract Cancer, Cholangiocarcinoma | Recruiting | CHA University | 100 | 2024-09-23 | 2026-03-18 | |
| Neurofibromatosis Type 1 Tumor Early Detection Study Liquid biopsy for MPNST development - Neurofibromatosis Type 1, Neurofibromatosis 1 | Enrolling by invitation | David Miller | 1000 | 2024-08-07 | 2026-08-31 | |
| GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES liquid biopsy - Pancreatic Adenocarcinoma | Enrolling by invitation | Karolinska University Hospital | 200 | 2024-05-02 | 2024-04-24 | |
| Pancreatic Cancer Initial Detection Via Liquid Biopsy Liquid biopsy - Pancreatic Cancer, IPMN, Pancreatic | Enrolling by invitation | Karolinska University Hospital | 200 | 2024-05-01 | 2024-04-24 | |
| Biomarkers to Detect Endocrine Therapy Resistance 18F-fluorofuranylnorprogesterone, Liquid Biopsy, Positron Emission Tomography/Computed Tomography - Metastatic Cancer, Breast Cancer | Phase 2 | Recruiting | University of Wisconsin, Madison | 8 | 2024-04-30 | 2026-08-25 |
| French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM) Blood sample/Liquid biopsy - Colorectal Cancer, Liver Metastases | Recruiting | University Hospital, Montpellier | 30 | 2024-04-15 | 2026-06-22 |
Showing 20 of 80. Sign in to see all of them.
Breast Neoplasms (10) · Colorectal Neoplasms (10) · Carcinoma, Non-Small-Cell Lung (8) · Lung Neoplasms (7) · Biliary Tract Neoplasms (5) · Pancreatic Neoplasms (5) · Disease (4) · Neoplasm Metastasis (4) · Neoplasm, Residual (4) · Neoplastic Cells, Circulating (4) · Melanoma (3) · Oropharyngeal Neoplasms (3) · Prostatic Neoplasms (3) · Recurrence (3) · Squamous Cell Carcinoma of Head and Neck (3)
CHA University (5) · University Hospital, Montpellier (4) · Centro di Riferimento Oncologico - Aviano (3) · Nanfang Hospital, Southern Medical University (3) · Assistance Publique - Hôpitaux de Paris (2) · City of Hope Medical Center (2) · Fundacion Clinic per a la Recerca Biomédica (2) · Institute of Oncology Ljubljana (2) · Istituto Clinico Humanitas (2) · Karolinska University Hospital (2) · Masaryk Memorial Cancer Institute (2) · SOLTI Breast Cancer Research Group (2) · University Health Network, Toronto (2) · Xinqiao Hospital of Chongqing (2) · Australian & New Zealand Children's Haematology/Oncology Group (1)
France (10) · Italy (10) · United States (10) · China (7) · Spain (6) · South Korea (5) · Belgium (3) · Canada (3) · Czechia (3) · Netherlands (3) · Denmark (2) · Germany (2) · Slovenia (2) · Sweden (2) · Switzerland (2)
Hong Jae Chon, MD. PhD (2) · Anja Wagner, Dr. (1) · Benedikt Westphalen (1) · Camilla Nero (1) · Christian Von Buchwald, MD, DMSc (1) · Christian von Buchwald, Professor, MD, DMSci (1) · Claus Lindbjerg Andersen, MD (1) · Cortot Alexis, Pr (1) · Dan Raz (1) · Dan Raz, MD (1) · David S Shulman, MD (1)
PMID 10197236, PMID 10636102, PMID 11215292, PMID 12522257, PMID 12949711, PMID 14515284, PMID 15654796, PMID 18076015, PMID 18670422, PMID 20375404, PMID 23684708, PMID 26311728, PMID 26622800, PMID 27384348, PMID 28383420, PMID 28445469, PMID 31253124, PMID 32293728, PMID 32832493, PMID 33798493, PMID 34759042, PMID 35967452, PMID 36127090, PMID 37075781, PMID 37488448, PMID 37490292, PMID 37760576, PMID 38319896, PMID 38520712, PMID 38650446, PMID 39748640, PMID 40361171, PMID 41778764, PMID 42384236, PMID 9438854
P30CA033572 (2), P30CA014089 (1), R43CA257133 (1)